Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Total assets by reportable segment) (Details)

v3.22.2
Segment Information (Total assets by reportable segment) (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]    
Intangible asset, net $ 29,440 $ 12,552
Tangible assets 334,515 383,951
Total assets 363,955 396,503
Dermatology Products Sales [Member]    
Segment Reporting Information [Line Items]    
Intangible asset, net 29,440 12,552
Tangible assets 84,056 84,732
Total assets 113,496 97,284
Pharmaceutical and Biotechnology Product Development [Member]    
Segment Reporting Information [Line Items]    
Tangible assets 250,459 299,219
Total assets $ 250,459 $ 299,219